Evidence map›Paper›PMID 24361339›Full record

ReviewDrug discovery today2014

In vitro models of the metastatic cascade: from local invasion to extravasation.

S Bersini, J S Jeon, Matteo Moretti, R D Kamm

Abstract readReview
In one paragraph

Review in Drug discovery today, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vascularized Biomaterials to Study Cancer Metastasis.Advanced healthcare materials · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Recent Advances in Body-on-a-Chip Systems.Analytical chemistry · 2019
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S BersiniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Piazza Leonardo da Vinci 32, 20133 Milano, Italy; Cell and Tissue Engineering Lab, IRCCS Istituto Ortopedico Galeazzi, Via R. Galeazzi 4, 20161 Milano, Italy.
J S JeonDepartment of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Matteo MorettiCell and Tissue Engineering Lab, IRCCS Istituto Ortopedico Galeazzi, Via R. Galeazzi 4, 20161 Milano, Italy. Electronic address: matteo.moretti@grupposandonato.it.
R D KammDepartment of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA. Electronic address: rdkamm@mit.edu.

Funding

Microfluidic 3D Assays for Metastatic CancerR33CA174550 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KAMM, ROGER D · 2013 to 2015
$1.1M
Microfluidic 3D Scaffold Assay for Cancer Cell Migration and IntravasationR21CA140096 · NCI · CHARLES STARK DRAPER LABORATORY · PI CHAREST, JOSEPH L. · 2009 to 2011
$672k
NCI NIH HHS R21 CA140096NCI NIH HHS R33 CA174550NCI NIH HHS R33 CA174550-01
6 · The paper itself

Abstract

A crucial event in the metastatic cascade is the extravasation of circulating cancer cells from blood capillaries to the surrounding tissues. The past 5 years have been characterized by a significant evolution in the development of in vitro extravasation models, which moved from traditional transmigration chambers to more sophisticated microfluidic devices, enabling the study of complex cell-cell and cell-matrix interactions in multicellular, controlled environments. These advanced assays could be applied to screen easily and rapidly a broad spectrum of molecules inhibiting cancer cell endothelial adhesion and extravasation, thus contributing to the design of more focused in vivo tests.

Indexed as

AnimalsCell Line, TumorHumansMicrofluidic Analytical TechniquesNeoplasm InvasivenessNeoplasmsNeoplastic Cells, CirculatingSignal Transduction

Identifiers

PMID24361339
PMCPMC4048792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.